annual D&A:
$5.00B-$46.22M(-0.92%)Summary
- As of today (May 29, 2025), TAK annual depreciation & amortization is $5.00 billion, with the most recent change of -$46.22 million (-0.92%) on March 1, 2025.
- During the last 3 years, TAK annual D&A has fallen by -$195.75 million (-3.77%).
- TAK annual D&A is now -6.91% below its all-time high of $5.37 billion, reached on March 31, 2020.
Performance
TAK Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.25B+$93.22M(+8.05%)Summary
- As of today (May 29, 2025), TAK quarterly depreciation & amortization is $1.25 billion, with the most recent change of +$93.22 million (+8.05%) on March 1, 2025.
- Over the past year, TAK quarterly D&A has dropped by -$128.13 million (-9.29%).
- TAK quarterly D&A is now -10.90% below its all-time high of $1.40 billion, reached on March 31, 2022.
Performance
TAK quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.00B-$128.13M(-2.50%)Summary
- As of today (May 29, 2025), TAK TTM depreciation & amortization is $5.00 billion, with the most recent change of -$128.13 million (-2.50%) on March 1, 2025.
- Over the past year, TAK TTM D&A has dropped by -$46.22 million (-0.92%).
- TAK TTM D&A is now -6.91% below its all-time high of $5.37 billion, reached on March 31, 2020.
Performance
TAK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TAK Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.9% | -9.3% | -0.9% |
| 3 y3 years | -3.8% | -10.9% | -3.8% |
| 5 y5 years | -6.9% | -6.8% | -6.9% |
TAK Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +1.6% | -10.9% | +9.8% | -3.8% | +1.6% |
| 5 y | 5-year | -6.9% | +1.6% | -10.9% | +9.8% | -6.9% | +1.6% |
| alltime | all time | -6.9% | +2095.1% | -10.9% | +435.8% | -6.9% | +1506.6% |
TAK Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $5.00B(-0.9%) | $1.25B(+8.1%) | $5.00B(-2.5%) |
| Dec 2024 | - | $1.16B(-14.7%) | $5.13B(-1.1%) |
| Sep 2024 | - | $1.36B(+10.0%) | $5.18B(+3.1%) |
| Jun 2024 | - | $1.23B(-10.6%) | $5.03B(-0.3%) |
| Mar 2024 | $5.04B(+2.5%) | $1.38B(+13.6%) | $5.04B(+0.5%) |
| Dec 2023 | - | $1.21B(+0.9%) | $5.02B(+0.1%) |
| Sep 2023 | - | $1.20B(-3.8%) | $5.01B(+1.3%) |
| Jun 2023 | - | $1.25B(-7.6%) | $4.95B(+0.6%) |
| Mar 2023 | $4.92B(-5.3%) | $1.35B(+12.0%) | $4.92B(-1.0%) |
| Dec 2022 | - | $1.21B(+6.0%) | $4.97B(-0.1%) |
| Sep 2022 | - | $1.14B(-6.8%) | $4.98B(-2.6%) |
| Jun 2022 | - | $1.22B(-13.0%) | $5.11B(-1.6%) |
| Mar 2022 | $5.19B(-1.6%) | $1.40B(+15.7%) | $5.19B(+2.9%) |
| Dec 2021 | - | $1.21B(-4.5%) | $5.05B(-3.2%) |
| Sep 2021 | - | $1.27B(-2.7%) | $5.21B(-1.1%) |
| Jun 2021 | - | $1.31B(+4.0%) | $5.27B(-0.2%) |
| Mar 2021 | $5.28B(-1.7%) | $1.26B(-9.1%) | $5.28B(-1.6%) |
| Dec 2020 | - | $1.38B(+4.0%) | $5.37B(+1.6%) |
| Sep 2020 | - | $1.33B(+0.9%) | $5.28B(-0.7%) |
| Jun 2020 | - | $1.32B(-2.0%) | $5.32B(-1.0%) |
| Mar 2020 | $5.37B(+140.4%) | $1.34B(+3.7%) | $5.37B(+2.7%) |
| Dec 2019 | - | $1.29B(-5.1%) | $5.23B(+22.6%) |
| Sep 2019 | - | $1.36B(-0.3%) | $4.27B(+31.3%) |
| Jun 2019 | - | $1.37B(+13.8%) | $3.25B(+45.4%) |
| Mar 2019 | $2.23B(+35.9%) | $1.20B(+262.2%) | $2.23B(+58.2%) |
| Dec 2018 | - | $332.05M(-4.0%) | $1.41B(-5.9%) |
| Sep 2018 | - | $346.02M(-2.1%) | $1.50B(-5.2%) |
| Jun 2018 | - | $353.56M(-7.0%) | $1.58B(-3.6%) |
| Mar 2018 | $1.64B(+3.7%) | $380.30M(-9.7%) | $1.64B(+9.8%) |
| Dec 2017 | - | $421.23M(-1.8%) | $1.50B(+7.8%) |
| Sep 2017 | - | $428.96M(+3.8%) | $1.39B(-12.8%) |
| Jun 2017 | - | $413.29M(+77.0%) | $1.59B(+0.5%) |
| Mar 2017 | $1.59B | $233.48M(-25.4%) | $1.59B(-11.9%) |
| Dec 2016 | - | $313.14M(-50.5%) | $1.80B(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $633.00M(+56.1%) | $1.91B(+15.7%) |
| Jun 2016 | - | $405.57M(-9.5%) | $1.65B(+0.1%) |
| Mar 2016 | $1.64B(-31.1%) | $448.05M(+6.9%) | $1.64B(-18.0%) |
| Dec 2015 | - | $419.22M(+12.1%) | $2.01B(-9.8%) |
| Sep 2015 | - | $373.99M(-7.3%) | $2.22B(-4.3%) |
| Jun 2015 | - | $403.60M(-50.1%) | $2.32B(-2.7%) |
| Mar 2015 | $2.39B(+10.8%) | $808.72M(+26.8%) | $2.39B(+1.7%) |
| Dec 2014 | - | $637.62M(+34.9%) | $2.35B(+8.5%) |
| Sep 2014 | - | $472.71M(+1.2%) | $2.16B(+0.3%) |
| Jun 2014 | - | $467.23M(-39.3%) | $2.16B(+0.1%) |
| Mar 2014 | $2.15B(-28.0%) | $769.27M(+69.3%) | $2.15B(+55.6%) |
| Dec 2013 | - | $454.35M(-2.5%) | $1.38B(+48.8%) |
| Sep 2013 | - | $466.02M(+0.4%) | $930.41M(+100.4%) |
| Jun 2013 | - | $464.39M(+46.4%) | $464.39M(-62.5%) |
| Mar 2013 | $2.99B(+57.2%) | - | - |
| Mar 2012 | $1.90B(+53.5%) | - | - |
| Mar 2011 | $1.24B(+0.2%) | $317.18M(-2.9%) | $1.24B(+5.1%) |
| Dec 2010 | - | $326.62M(+4.0%) | $1.18B(-1.0%) |
| Sep 2010 | - | $314.00M(+11.5%) | $1.19B(-1.4%) |
| Jun 2010 | - | $281.67M(+9.4%) | $1.21B(-2.4%) |
| Mar 2010 | $1.24B(+4.2%) | $257.43M(-23.9%) | $1.24B(+26.3%) |
| Dec 2009 | - | $338.22M(+2.3%) | $980.10M(+52.7%) |
| Sep 2009 | - | $330.75M(+6.3%) | $641.88M(+106.3%) |
| Jun 2009 | - | $311.13M | $311.13M |
| Mar 2009 | $1.19B(+327.0%) | - | - |
| Mar 2008 | $278.09M(+12.8%) | - | - |
| Mar 2007 | $246.53M(-3.0%) | - | - |
| Mar 2006 | $254.08M(-12.7%) | - | - |
| Mar 2005 | $290.98M(+16.8%) | - | - |
| Mar 2004 | $249.16M(+1.2%) | - | - |
| Mar 2003 | $246.14M(+8.1%) | - | - |
| Mar 2002 | $227.72M(-25.2%) | - | - |
| Mar 2001 | $304.53M(+1.2%) | - | - |
| Mar 2000 | $300.85M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual depreciation & amortization?
- What is the all time high annual D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual D&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly D&A year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM D&A year-on-year change?
What is Takeda Pharmaceutical Company Limited annual depreciation & amortization?
The current annual D&A of TAK is $5.00B
What is the all time high annual D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual depreciation & amortization is $5.37B
What is Takeda Pharmaceutical Company Limited annual D&A year-on-year change?
Over the past year, TAK annual depreciation & amortization has changed by -$46.22M (-0.92%)
What is Takeda Pharmaceutical Company Limited quarterly depreciation & amortization?
The current quarterly D&A of TAK is $1.25B
What is the all time high quarterly D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly depreciation & amortization is $1.40B
What is Takeda Pharmaceutical Company Limited quarterly D&A year-on-year change?
Over the past year, TAK quarterly depreciation & amortization has changed by -$128.13M (-9.29%)
What is Takeda Pharmaceutical Company Limited TTM depreciation & amortization?
The current TTM D&A of TAK is $5.00B
What is the all time high TTM D&A for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM depreciation & amortization is $5.37B
What is Takeda Pharmaceutical Company Limited TTM D&A year-on-year change?
Over the past year, TAK TTM depreciation & amortization has changed by -$46.22M (-0.92%)